Hogan Lovells Advises Aztiq on Strategic Sale of Adalvo to EQT Partners

"Hogan Lovells has advised Icelandic private equity firm Aztiq on the sale of its global B2B pharmaceutical business, Adalvo, to EQT Partners AG, with Aztiq reinvesting as a minority stakeholder. The transaction, which closed on October 22, 2025, involved collaboration across multiple jurisdictions and highlighted the role of private capital in the life sciences sector. The Hogan Lovells team, led by partners Georgy Kalashnikov, Simon Grimshaw, and Hannah Logan, emphasized the importance of cross-practice collaboration in achieving successful outcomes for clients."

Hogan Lovells acted as legal counsel for Aztiq, an Icelandic private equity firm, in the sale of its global B2B pharmaceutical business, Adalvo, to EQT Partners AG. The transaction, which closed on 22 October 2025, involved Aztiq's reinvestment as a minority holder alongside EQT. Prior to the closing, Metric Capital Partners converted its existing debt investment into equity in the seller, with existing shareholders, including Aztiq, Metric, and management, also reinvesting a portion of their proceeds in the new EQT equity structure. This sale marks a significant strategic milestone for both Aztiq and Adalvo, highlighting the role of private capital in fostering growth and innovation in the life sciences sector. The Hogan Lovells team was led by corporate partners Georgy Kalashnikov, Simon Grimshaw, and Hannah Logan. They were supported by associates Taylor Harris, Ilya Skalkov, Nick Cooke, Imogen Thwaites, Ekaterina Nuzhdova, Ben Littlewood, Hope O’Dwyer, and Hannah Dingemans. Additional support came from partners Penny Powell (SOAR), Jane Summerfield (Pharmaceuticals), Paul Mullen, and Louise Leung (Banking).

Hogan Lovells Advises Aztiq on Strategic Sale of Adalvo to EQT Partners

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads